Please check back for updates on speakers, agenda, and registration information.
SDDS 2025: Stanford Drug Discovery Symposium
Welcome to the 2025 Stanford Drug Discovery Symposium. This event has become a cornerstone in the drug discovery community for networking and collaboration. SDDS 2025 offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate two days of exciting talks and discussions, including the return of our poster session. We look forward to welcoming you to Stanford for SDDS 2025.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
New Venue!
We are excited to announce a new venue for SDDS 2025, located at the Frances C. Arrillaga Alumni Center at Stanford. This new space offers an enhanced attendee experience, with more room for networking, an expanded poster session, and convenient parking. We look forward to a dynamic environment for collaboration and innovation.
Lifetime Achievement Awardees
Jens Juul Holst, MD, DMSc
Professor, Department of Biomedical Sciences and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Joel Habener, MD
Professor of Medicine, Harvard Medical School
Lotte Bjerre Knudsen, DMSc
Chief Scientific Advisor, Novo Nordisk
Participants
Srini Akkaraju, MD, PhD
Founder & Managing Partner, Samsara BioCapital.
Robert Bradway, MBA
Chairman and CEO, Amgen
Patrizia Cavazzoni, MD
Former Director, Center for Drug Evaluation and Resarch Food and Drug Administration
Levi Garraway, MD, PhD
Executive Vice President, Head of Global Product Dev, and CMO, Roche / Genentech
Alexander Hardy, MBA
President and CEO, BioMarin
Karin Immergluck, PhD
Associate Vice Provost, Office of Technology Licensing, Stanford
Christoph Lengauer, MD, PhD
Co-Founder and CSO, Curie.Bio
Mark McClellan, MD, PhD
Director and Robert J. Margolis, MD, Professor of Business, Medicine, and Policy, Margolis Institute for Health Policy, Duke University
Andrew Plump, MD, PhD
President of Research and Development, Takeda
Randy Schekman, PhD
Nobel Laureate, 2013; Professor of Molecular and Cell Biology, University of California, Berkeley
Caroline Stout
Partner, EcoRI Capital
Jonathan Thomas, PhD, JD
President and CEO, CIRM
Carolyn Bertozzi, PhD
Nobel Laureate 2022
Baker Family Director of Stanford ChEM-H
Robert Blum, MBA
President and CEO,
Cytokinetics
Navin Chaddha, MS
Managing Partner, Mayfield
Jane Grogan, PhD
Executive Vice President and Head of Research, Biogen
Stephen Hoge, MD
President,
Moderna
Karen Knudsen, MBA, PhD
CEO, American Cancer Society & American Cancer Society Cancer Action Network
Ashley Magargee, MBA
CEO, Genentech
Lloyd Minor, MD
Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine
Stephen Quake, D.Phil
Head of Science, Chan Zuckerberg Initiative
Marcus Schindler, PhD
Executive Vice President, Research & Early Development, and CSO, Novo Nordisk
Thomas Südhof, MD
Nobel Laureate 2013; Avram Goldstein Professor and Prof of Neurosurgery, Stanford University
Anne Wojcicki
CEO and Co-Founder, 23andMe
Jay Bradner, MD
Executive Vice President, R&D, and CSO, Amgen
Rob Califf, MD
Former Commissioner, U.S. Food and Drug Administration
Jennifer Doudna, PhD
Nobel Laureate 2020; Li Ka Shing Chancellor’s Chair, Professor, UC Berkley
Aida Habtezion, MD
Chief Medical Officer and Head of Worldwide Medical and Security, Pfizer
Thomas Hudson, MD
Versant Ventures
Samarth Kulkarni, PhD
CEO and Chairman of the Board, CRISPR Therapeutics
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Becky Pferdehirt, PhD
Investing Partner, Andreessen Horowitz
John Reed, MD, PhD
Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson
Dan Sheeran, MBA
General Manager, Healthcare and Life Science, Amazon Web Services
Marc Tessier-Lavigne, PhD
CEO, Xaira Therapeutics
George Yancopoulos, MD, PhD
President and Chief Scientific Officer, Regeneron
Event Program & Poster
TBD
FAQs
Foundation Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Media Partners
Organizers
Amanda Chase, PhD
Associate Director of Strategic Research Development
Stanford Cardiovascular Institute
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Francesca Mae G. Tongco, MS-HCA
Project Coordinator
Stanford Cardiovascular Institute
For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.